|
Chimeric antigen receptor (CAR) T-cell therapy Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Axi-cel, YESCARTA
Tampa, Florida1 trial
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
Moffitt Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.